|
EP1127882A1
(en)
|
2000-01-25 |
2001-08-29 |
Pfizer Products Inc. |
Tetrazole compounds as thyroid receptor ligands
|
|
US6664291B2
(en)
|
2000-03-31 |
2003-12-16 |
Pfizer, Inc. |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
|
FI107018B
(fi)
*
|
2000-04-06 |
2001-05-31 |
Ipsat Therapies Oy |
Dermatologinen käyttö ja valmiste
|
|
US6395784B1
(en)
*
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
|
DE10038007A1
(de)
*
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Neue Amino-und Amido-Diphenylether für Arzneimittel
|
|
US7163918B2
(en)
|
2000-08-22 |
2007-01-16 |
New River Pharmaceuticals Inc. |
Iodothyronine compositions
|
|
GB0029100D0
(en)
*
|
2000-11-29 |
2001-01-10 |
Karobio Ab |
Compounds active at the glucocorticoid receptor
|
|
WO2002051805A1
(de)
*
|
2000-12-27 |
2002-07-04 |
Bayer Aktiengesellschaft |
Indol-derivate
|
|
US7504435B2
(en)
|
2001-01-31 |
2009-03-17 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method for stimulating weight loss and/or for lowering triglycerides in patients
|
|
AU2002237298B2
(en)
*
|
2001-02-08 |
2006-08-03 |
Karo Bio Ab |
Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
|
|
US6777442B2
(en)
|
2001-03-12 |
2004-08-17 |
Bayer Aktiengesellschaft |
Diphenyl derivatives
|
|
DE10122443A1
(de)
*
|
2001-05-09 |
2002-11-14 |
Bayer Ag |
Amido-Diphenyl-Derivate
|
|
GB0120691D0
(en)
*
|
2001-08-24 |
2001-10-17 |
Karobio Ab |
Novel Compounds
|
|
US7279593B2
(en)
|
2001-08-24 |
2007-10-09 |
Karo Bio Ab |
Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
|
|
ES2253495T3
(es)
|
2001-09-26 |
2006-06-01 |
Pfizer Products Inc. |
Acidos indol carboxilicos como ligandos de receptores tiroideos.
|
|
EP1471049A4
(en)
|
2002-01-30 |
2006-08-16 |
Kissei Pharmaceutical |
NEW THYROIDIAN HORMONE RECEPTOR LIGAND, MEDICINAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF
|
|
GB0208384D0
(en)
*
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
|
GB0215978D0
(en)
|
2002-07-10 |
2002-08-21 |
Karobio Ab |
Novel compounds
|
|
SI2208727T1
(sl)
*
|
2002-09-19 |
2012-11-30 |
Lilly Co Eli |
Diaril etri kot antagonisti opioidnega receptorja
|
|
EP1477475A1
(en)
*
|
2003-05-16 |
2004-11-17 |
Procorde GmbH |
Compounds for use as a medicine increasing the contractility of a heart, a heart muscle or cells of a heart muscle
|
|
ITRM20030363A1
(it)
*
|
2003-07-24 |
2005-01-25 |
Fernando Goglia |
Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
|
|
US7317109B2
(en)
*
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7576121B2
(en)
*
|
2003-11-12 |
2009-08-18 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7767828B2
(en)
*
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7674913B2
(en)
*
|
2003-11-12 |
2010-03-09 |
Phenomix Corporation |
Heterocyclic boronic acid compounds
|
|
US7829552B2
(en)
|
2003-11-19 |
2010-11-09 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing thyromimetics
|
|
US7504413B2
(en)
|
2004-05-06 |
2009-03-17 |
Cytokinetics, Inc. |
N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
|
|
US7618981B2
(en)
|
2004-05-06 |
2009-11-17 |
Cytokinetics, Inc. |
Imidazopyridinyl-benzamide anti-cancer agents
|
|
US7795448B2
(en)
|
2004-05-06 |
2010-09-14 |
Cytokinetics, Incorporated |
Imidazoyl-benzamide anti-cancer agents
|
|
UA87854C2
(en)
*
|
2004-06-07 |
2009-08-25 |
Мерк Энд Ко., Инк. |
N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
|
|
US7317024B2
(en)
|
2005-01-13 |
2008-01-08 |
Bristol-Myers Squibb Co. |
Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
EP2527337A1
(en)
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
|
US7521557B2
(en)
|
2005-05-20 |
2009-04-21 |
Bristol-Myers Squibb Company |
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
US7825139B2
(en)
*
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
JP2008542301A
(ja)
|
2005-05-26 |
2008-11-27 |
メタバシス・セラピューティクス・インコーポレイテッド |
脂肪性肝疾患の処置のための甲状腺ホルモン様薬剤
|
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
US7629342B2
(en)
|
2005-06-17 |
2009-12-08 |
Bristol-Myers Squibb Company |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
|
US7452892B2
(en)
|
2005-06-17 |
2008-11-18 |
Bristol-Myers Squibb Company |
Triazolopyrimidine cannabinoid receptor 1 antagonists
|
|
US7317012B2
(en)
|
2005-06-17 |
2008-01-08 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoind-1 receptor modulators
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
EP1908466B1
(en)
|
2005-07-19 |
2014-02-19 |
Daiichi Sankyo Company, Limited |
Substituted propanamide derivative and pharmaceutical composition containing the same
|
|
CA2617969A1
(en)
*
|
2005-08-10 |
2007-02-15 |
Takeda Pharmaceutical Company Limited |
Therapeutic agent for diabetes
|
|
US7795436B2
(en)
|
2005-08-24 |
2010-09-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
|
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
|
US7488725B2
(en)
|
2005-10-31 |
2009-02-10 |
Bristol-Myers Squibb Co. |
Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods
|
|
TW200738621A
(en)
*
|
2005-11-28 |
2007-10-16 |
Astrazeneca Ab |
Chemical process
|
|
US7553836B2
(en)
|
2006-02-06 |
2009-06-30 |
Bristol-Myers Squibb Company |
Melanin concentrating hormone receptor-1 antagonists
|
|
KR20080108539A
(ko)
*
|
2006-04-12 |
2008-12-15 |
머크 앤드 캄파니 인코포레이티드 |
피리딜 아미드 ｔ-형 칼슘 채널 길항제
|
|
WO2007120083A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Astrazeneca Ab |
The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
|
|
FR2900404B1
(fr)
*
|
2006-04-27 |
2008-07-18 |
Sod Conseils Rech Applic |
Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament
|
|
WO2007132475A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Cadila Healthcare Limited |
Selective tr-beta 1 agonist
|
|
EP2021014A1
(en)
|
2006-05-26 |
2009-02-11 |
Brystol-Myers Squibb Company |
Sustained release glp-1 receptor modulators
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
JP2010508358A
(ja)
|
2006-11-01 |
2010-03-18 |
ブリストル−マイヤーズ スクイブ カンパニー |
グルココルチコイド受容体、ＡＰ−１、および／またはＮＦ−κＢ活性の調節剤、並びにその使用
|
|
RU2395489C2
(ru)
*
|
2006-11-01 |
2010-07-27 |
Институт элементоорганических соединений имени А.Н.Несмеянова Российской академии наук (ИНЭОС РАН) |
[f-18] меченная l-глютаминовая кислота, [f-18] меченный l-глютамин, их производные и их применение, а также способ их получения
|
|
US7968577B2
(en)
|
2006-11-01 |
2011-06-28 |
Bristol-Myers Squibb Company |
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
EP2124873B1
(en)
|
2007-01-31 |
2016-01-06 |
Basf Se |
Cationic dyes
|
|
US8399518B2
(en)
|
2007-02-27 |
2013-03-19 |
University Of Arizona Office Of Technology Transfer |
Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome
|
|
TW200904405A
(en)
|
2007-03-22 |
2009-02-01 |
Bristol Myers Squibb Co |
Pharmaceutical formulations containing an SGLT2 inhibitor
|
|
JP2010524953A
(ja)
|
2007-04-17 |
2010-07-22 |
ブリストル−マイヤーズ スクイブ カンパニー |
縮合ヘテロ環１１−β−ヒドロキシステロイドデヒドロゲナーゼＩ型阻害剤
|
|
PE20090696A1
(es)
|
2007-04-20 |
2009-06-20 |
Bristol Myers Squibb Co |
Formas cristalinas de saxagliptina y procesos para preparar las mismas
|
|
US20090011994A1
(en)
|
2007-07-06 |
2009-01-08 |
Bristol-Myers Squibb Company |
Non-basic melanin concentrating hormone receptor-1 antagonists and methods
|
|
CN101808995A
(zh)
|
2007-07-27 |
2010-08-18 |
百时美施贵宝公司 |
新颖的葡糖激酶激活剂及其使用方法
|
|
AU2008302570B2
(en)
*
|
2007-09-20 |
2012-05-31 |
Irm Llc |
Compounds and compositions as modulators of GPR119 activity
|
|
WO2009054984A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Merck & Co., Inc. |
Heterocycle phenyl amide t-type calcium channel antagonists
|
|
EP2209780B1
(en)
|
2007-11-01 |
2014-01-01 |
Bristol-Myers Squibb Company |
Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf- kappa b activity and use thereof
|
|
GB0725214D0
(en)
*
|
2007-12-24 |
2008-02-06 |
Karobio Ab |
Pharmaceutical compounds
|
|
PE20091928A1
(es)
|
2008-05-29 |
2009-12-31 |
Bristol Myers Squibb Co |
Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
|
|
MX2011004347A
(es)
*
|
2008-10-27 |
2011-05-25 |
Cadila Healthcare Ltd |
Ligandos de receptores de la tiroides.
|
|
KR101657323B1
(ko)
|
2008-11-19 |
2016-09-13 |
포라 가세이 고교 가부시키가이샤 |
주름 개선제
|
|
WO2010086878A2
(en)
|
2009-01-09 |
2010-08-05 |
Cadila Healthcare Limited |
Thyroid receptor modulators
|
|
CA2756786A1
(en)
|
2009-03-27 |
2010-09-30 |
Bristol-Myers Squibb Company |
Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
|
|
AU2010240200B2
(en)
*
|
2009-04-20 |
2014-03-13 |
Mitsubishi Tanabe Pharma Corporation |
Novel thyroid hormone beta receptor agonist
|
|
CN105193761B
(zh)
|
2009-11-13 |
2019-12-06 |
阿斯利康(瑞典)有限公司 |
双层片剂
|
|
CN102740839B
(zh)
|
2009-11-13 |
2015-05-06 |
阿斯利康(瑞典)有限公司 |
立即释放片剂
|
|
US20120294936A1
(en)
|
2009-11-13 |
2012-11-22 |
Astrazeneca Uk Limited |
Reduced mass metformin formulations
|
|
WO2011103126A1
(en)
*
|
2010-02-17 |
2011-08-25 |
Ampla Pharmaceuticals Inc. |
Treatment of metabolic syndrome with piperidine amides
|
|
ES2559209T3
(es)
|
2010-04-14 |
2016-02-11 |
Bristol-Myers Squibb Company |
Nuevos activadores de la glucocinasa y métodos de uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
WO2011133920A1
(en)
|
2010-04-23 |
2011-10-27 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
ES2533065T3
(es)
|
2010-07-09 |
2015-04-07 |
Pfizer Limited |
Bencenosulfonamidas útiles como inhibidores de los canales de sodio
|
|
CA2804877A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
|
|
CA2804351A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
ES2525581T3
(es)
|
2010-07-12 |
2014-12-26 |
Pfizer Limited |
Derivados de N-sulfonilbenzamida útiles como inhibidores del canal de sodio dependiente de voltaje
|
|
WO2012007868A2
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
US9102621B2
(en)
|
2010-07-12 |
2015-08-11 |
Pfizer Limited |
Acyl sulfonamide compounds
|
|
EP2773641B1
(en)
|
2011-10-31 |
2017-09-27 |
Xenon Pharmaceuticals Inc. |
Biaryl ether sulfonamides and their use as therapeutic agents
|
|
WO2013064983A1
(en)
|
2011-10-31 |
2013-05-10 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
WO2013088315A1
(en)
|
2011-12-15 |
2013-06-20 |
Pfizer Limited |
Sulfonamide derivatives
|
|
CA2860553C
(en)
*
|
2012-01-04 |
2016-08-23 |
Pfizer Limited |
N-aminosulfonyl benzamides
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
CN102718718B
(zh)
*
|
2012-05-31 |
2014-09-24 |
绍兴文理学院 |
一种3,5-二溴-4-（5-苯并咪唑氧基）苯乙酸的制备方法
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
EP2892897A1
(en)
|
2012-09-05 |
2015-07-15 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
|
|
WO2014039411A1
(en)
|
2012-09-05 |
2014-03-13 |
Bristol-Myers Squibb Company |
Pyrrolone or pyrrolidinone melanin concentrating hormore receptor-1 antagonists
|
|
RU2015143906A
(ru)
|
2013-03-14 |
2017-04-18 |
Дженентек, Инк. |
Замещенные триазолопиридины и способы их применения
|
|
US9493429B2
(en)
|
2013-03-15 |
2016-11-15 |
Genentech, Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
US9593113B2
(en)
|
2013-08-22 |
2017-03-14 |
Bristol-Myers Squibb Company |
Imide and acylurea derivatives as modulators of the glucocorticoid receptor
|
|
AU2014356967A1
(en)
|
2013-11-27 |
2016-07-07 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
CN103709094B
(zh)
*
|
2014-01-07 |
2016-04-06 |
厦门大学 |
4-苯氧基苯甲酰胺类化合物及其制备方法和应用
|
|
JP2017525677A
(ja)
|
2014-07-07 |
2017-09-07 |
ジェネンテック， インコーポレイテッド |
治療用化合物及びその使用方法
|
|
BR112017024853A2
(pt)
|
2015-05-22 |
2018-08-07 |
Genentech Inc |
composto, composição farmacêutica, método para tratar uma doença ou condição em um mamífero, para tratamento de prurido em um mamífero, para tratamento ou profilaxia e uso de um composto
|
|
MA42683A
(fr)
|
2015-08-27 |
2018-07-04 |
Genentech Inc |
Composés thérapeutiques et leurs méthodes utilisation
|
|
SG10202007787RA
(en)
|
2015-09-28 |
2020-09-29 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
JP2018535234A
(ja)
|
2015-11-25 |
2018-11-29 |
ジェネンテック， インコーポレイテッド |
ナトリウムチャネル遮断薬として有用な置換ベンズアミド
|
|
WO2017172802A1
(en)
|
2016-03-30 |
2017-10-05 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
US11447460B2
(en)
|
2016-04-18 |
2022-09-20 |
Novartis Ag |
Compounds and compositions for treating conditions associated with NLRP activity
|
|
KR102537274B1
(ko)
*
|
2016-08-12 |
2023-05-25 |
오레곤 헬스 앤드 사이언스 유니버시티 |
아마이드 화합물, 이의 약학 조성물 및 이들을 이용하는 방법
|
|
SG11201903348UA
(en)
|
2016-10-17 |
2019-05-30 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
EP3541395A4
(en)
|
2016-11-21 |
2020-07-01 |
Viking Therapeutics, Inc. |
GLYCOGENOSIS TREATMENT METHODS
|
|
CN106588690B
(zh)
*
|
2016-12-19 |
2019-06-04 |
广西中医药大学 |
毛鸡骨草甲素Abrusamide的制备方法
|
|
CN110546148A
(zh)
|
2017-03-24 |
2019-12-06 |
基因泰克公司 |
作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
|
|
EP3634426A4
(en)
|
2017-06-05 |
2021-04-07 |
Viking Therapeutics, Inc. |
COMPOSITIONS FOR TREATMENT OF FIBROSE
|
|
CN111094554A
(zh)
|
2017-09-14 |
2020-05-01 |
国立研究开发法人理化学研究所 |
视网膜组织的制备方法
|
|
CN111417622A
(zh)
*
|
2017-10-17 |
2020-07-14 |
诺华炎症研究公司 |
用于治疗与nlrp活性相关的病症的磺胺类及其组合物
|
|
WO2019119673A1
(zh)
|
2017-12-19 |
2019-06-27 |
北京吉源生物科技有限公司 |
一种双基因修饰的干细胞及其用途
|
|
EP3759098A1
(en)
|
2018-02-26 |
2021-01-06 |
Genentech, Inc. |
Pyridine-sulfonamide compounds and their use against pain and related conditions
|
|
CA3094167A1
(en)
|
2018-03-22 |
2019-09-26 |
Viking Therapeutics, Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
|
CN111936494A
(zh)
|
2018-03-30 |
2020-11-13 |
豪夫迈·罗氏有限公司 |
作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
WO2020016335A1
(en)
|
2018-07-19 |
2020-01-23 |
Astrazeneca Ab |
Methods of treating hfpef employing dapagliflozin and compositions comprising the same
|
|
WO2020117962A1
(en)
|
2018-12-05 |
2020-06-11 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis and inflammation
|
|
JP2022513449A
(ja)
|
2018-12-12 |
2022-02-08 |
オートバーン セラピューティクス，インク． |
新規な甲状腺模倣物
|
|
EP3931180A1
(en)
|
2019-03-01 |
2022-01-05 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
|
SG11202109855PA
(en)
|
2019-03-13 |
2021-10-28 |
Sumitomo Dainippon Pharma Co Ltd |
Method for evaluating quality of transplant neural retina, and transplant neural retina sheet
|
|
US20220306630A1
(en)
*
|
2019-08-06 |
2022-09-29 |
Bristol-Myers Squibb Company |
AGONISTS OF ROR GAMMAt
|
|
IL293389B1
(en)
|
2019-11-29 |
2025-12-01 |
Autobahn Therapeutics Inc |
Novel thyromimetics
|
|
US12528761B2
(en)
|
2020-06-17 |
2026-01-20 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
|
EP4206321A4
(en)
|
2020-09-11 |
2024-05-01 |
Riken |
Complex containing neural retina-containing cell aggregates and matrix, and method for manufacturing same
|
|
WO2022054924A1
(ja)
|
2020-09-11 |
2022-03-17 |
大日本住友製薬株式会社 |
移植用組織のための媒体
|
|
CA3238664A1
(en)
|
2021-11-19 |
2023-05-25 |
Riken |
Production method for sheet-like retinal tissue
|
|
US12377058B1
(en)
|
2024-04-29 |
2025-08-05 |
Imam Mohammad Ibn Saud Islamic University |
Method for inhibiting proliferation of cancer cells
|